• Product name
    Anti-ADA antibody (HRP)
    See all ADA primary antibodies
  • Description
    Rabbit polyclonal to ADA (HRP)
  • Conjugation
  • Tested applications
    Suitable for: WB, ELISA, Dot blot, Electron Microscopymore details
  • Species reactivity
    Reacts with: Cow
  • Immunogen

    Adenosine Deaminase (Calf spleen).



Our Abpromise guarantee covers the use of ab34651 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
Dot blot
Electron Microscopy
  • Application notes
    Dot: Use at an assay dependent dilution.
    Immunoperoxidase Electron Microscopy: Use at an assay dependent dilution.
    ELISA: 1/20000 - 1/100000.
    This antibody has been assayed against 1.0µg of Adenosine Deaminase in a standard capture ELISA using ABTS (2,2'-azino-bis-[3-ethylbenthiazoline-6-sulfonic acid]) as a substrate for 30 minutes at RT.
    WB: Use at an assay dependent dilution. Predicted molecular weight: 104 kDa.
    Suitable for other peroxidase-antibody based assays.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • Function
      Catalyzes the hydrolytic deamination of adenosine and 2-deoxyadenosine. Plays an important role in purine metabolism and in adenosine homeostasis. Modulates signaling by extracellular adenosine, and so contributes indirectly to cellular signaling events. Acts as a positive regulator of T-cell coactivation, by binding DPP4. Its interaction with DPP4 regulates lymphocyte-epithelial cell adhesion.
    • Tissue specificity
      Found in all tissues, occurs in large amounts in T-lymphocytes and, at the time of weaning, in gastrointestinal tissues.
    • Involvement in disease
      Defects in ADA are the cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700]. SCID refers to a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients with SCID present in infancy with recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development. ADA-SCID is an autosomal recessive form accounting for about 50% of non-X-linked SCIDs. ADA deficiency has been diagnosed in chronically ill teenagers and adults (late or adult onset). Population and newborn screening programs have also identified several healthy individuals with normal immunity who have partial ADA deficiency.
    • Sequence similarities
      Belongs to the adenosine and AMP deaminases family.
    • Cellular localization
      Cell membrane. Cell junction. Cytoplasmic vesicle lumen. Cytoplasm. Colocalized with DPP4 at the cell junction in lymphocyte-epithelial cell adhesion.
    • Information by UniProt
    • Alternative names
      • ada antibody
      • ADA_HUMAN antibody
      • ADA1 antibody
      • Adenosine aminohydrolase antibody
      • Adenosine deaminase antibody
      see all

    References for Anti-ADA antibody (HRP) (ab34651)

    ab34651 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab34651.
    Please use the links above to contact us or submit feedback about this product.


    Sign up